Interviews

A vaccine .... forever

Posted April 09th, 2025

EMA has approved Kostaive, the first self-replicating vaccine.
What is it? What are the possible risks?
Dr. Maurizio Federico, director of the National Center for Global Health at the Istituto Superiore di Sanità,

and Dr. Patrizia Gentilini, a specialist in Oncology and Hematology, tell us about it.

1 comments

April 29th, 2025 03:59

Kostaive, EMA-approved, is a self-replicating vaccine raising both excitement and concern. Experts Federico and Gentilini discuss its potential benefits and unknown risks, a wild ride akin to a Moto X3M course – exhilarating but potentially dangerous. Careful consideration is crucial before widespread use.

Post a comments

Login or Register to leave a comment.